The ubiquitin proteasome system (UPS) is a vital cellular mechanism responsible for degradation of intracellular proteins participating in diverse biological processes [1] . The 
Parkinson's disease (PD) is a primary neurodegenerative movement disorder, pathologically characterized by relatively selective loss of nigral dopamine neurons. Mitochondrial dysfunction and oxidative stress have long been recognized as major events of nigral dopaminergic degeneration. A pathogenic role of mitochondrial dysfunction in PD is supported by PD modelling with mitochondrial complex I inhibitors and the observed mitochondrial complex I deficit in the substantia nigra and platelets of PD patients
. Mitochondrial dysfunction has been suggested to generate excessive free radical production, resulting in oxidative injury [5] . Furthermore, the recently discovered PD genes PINK1 and DJ-1 have been tightly linked to mitochondrial dysfunction or oxidative stress [4] . In addition to mitochondrial dysfunction and oxidative stress, emerging evidence indicates a defective ubiquitin proteasome degradation pathway may also play an important role in the pathogenesis of PD. Compromised proteasome function has been reported in the substantia nigra of post mortem brain samples from subjects with sporadic PD [6] as well as in experimental PD models [2, [7] [8] [9] [12] [13] [14] [15] , with the pathophysiological relevance of the observations to PD pathogenesis unknown. Recent finding by Bennett and the coworker revealed marked global alteration of ubiquitination systems in the mouse model of Huntington's disease, including the significant accumulation of K48 and K63 polyubiquitin chains [16] . Herein 
. Mutations in Parkin (a ubiquitin ligase) and Uch-L1 (a deubiquitin enzyme) have been linked to early onset PD. Despite the observation of proteasomal inhibition by mitochondrial complex I inhibitors [10] and profound mitochondrial pathology in cells exposed to low doses of proteasome inhibitor [11], little is known about how UPS impairment and mitochondrial dysfunction are mutually related in the degenerative processes of dopaminergic neurons. Paradoxically, several PD-related proteins including Parkin, ␣-synuclein and Uch-L1 (mutations of which are associated with familial PD) have been shown to facilitate the assembly of K63 polyubiquitin chains

Materials and methods
Cell culture, plasmid construction and stable expression
The immortalized rat mesencephalic dopaminergic neuronal (N27) cells were cultured as described previously [17] . N27 cells are widely used as a model system for studying cellular mechanisms of neurodegeneration in PD [18] [19] [20] [21] . Ubiquitin K48R 
DNA fragmentation and assays for proteasome and caspases
Quantification of DNA fragmentation using an ELISA kit and assays for proteasomal and caspase-3 and caspase-9 activities using fluorogenic substrates were conducted as described in our previous publications [17] . Figure 1A , 2.5-M MG-132 rapidly inhibited more than 80% of proteasomal activity within 5 min. This was followed by cytochrome c release from mitochondria to cytosol (Fig. 1B) and a dramatic activation of caspase-9 (Fig. 1C) Fig. 2C) , at the interface approximately midway through the gradient, which is consistent with a previous study that used a similar mitochondrial purification procedure [23] . Importantly, ubiquitin conjugates of [24] . Incubation of mitochondria with the high pH buffer released the mitochondrial outer membrane marker VDAC together with ubiquitin conjugates, but not the inner membrane marker COX IV, into the supernatant (Fig. 2D) . However, a substantial portion of the ubiquitin conjugates was resistant to the high pH buffer and remained associated with the mitochondrial pellet (Fig. 2D) . This observation raises the possibility that some mitochondrial membrane proteins with tight membrane interaction could undergo hyperubiquitination.
To determine further whether mitochondrial membrane proteins readily undergo ubiquitination, we performed an in vitro cell-free ubiquitination assay in isolated mitochondria. As shown in Figure 2E, expressing cells (Fig. 3B) . This corroborates the precise processing of the fusion proteins into His6-tagged ubiquitin, as reported previously [22, 25] (Fig. 3C) , whereas 1-hr exposure to 1-M rotenone induced mitochondrial superoxide production (positive control). Similarly, analysis of cellular glutathione revealed no significant difference in the three different mutant cells (Fig. 3D) . (Fig. 4B), caspase-3 (Fig. 4C) and DNA fragmentation (Fig. 4D) was also significantly attenuated in Fig. 3 (Fig. 4B-D) , suggesting that K63 may be neuroprotective in dopaminergic cells.
Effect of wild-type, K48R-Ub and K63R-Ub on proteasomal inhibitor-induced mitochondrial apoptosis
K48R-Ub mutant cells compared to cells expressing wt-Ub alone. This suggests the assembly of K48 polyubiquitin chains plays a causal role in activation of mitochondrial apoptosis. Of note, the anti-apoptotic effect of the K48R-Ub mutant is Lys48 ubiquitination site-specific, since K63R-Ub mutation did not provide similar protection. On the contrary, K63R-Ub mutant render the dopaminergic cells more susceptible to MG-132-induced apoptosis
Discussion
Impairment in the ubiquitin-proteasome system and mitochondrial dysfunction have both been implicated in the pathogenesis of PD. This study revealed a prominent accumulation of polyubiquitinated proteins in the mitochondria during the activation of mitochondrial apoptosis in dopaminergic neuronal cells following proteasome inhibition. Intriguingly, the same Lys to Arg mutation at different polyubiquitination sites, Lys-48 or Ϫ63, appeared to exert opposite effects on the activation of the mitochondrial apoptosis cascade, indicating distinctly different roles for these two types of polyubiquitin in dopaminergic cell survival. Proteasome inhibitors have been previously shown to mimic some key features of PD, including dopamine cell death [2], one of the fundamental pathological features of PD, in vivo and in vitro.
In this dopaminergic cell model of PD, we found that proteasome inhibition triggers the activation of the mitochondrial apoptotic cascade (Fig. 1A) . The Fig. 2A-C) , indicative of the potential role of the mitochondrion as an early key sensor of polyubiquitinated protein stress following proteasome dysfunction in dopaminergic cells. The similar elevation of ubiquitin conjugates was also manifested in the microsomal, cytosolic and nuclear fractions, although to a much lower extent (Fig. 2A) . In addition to oxidative stress, ER stress may play a role in the cell death processes in PD [28] [29] [30] [24] , implied a preferential association of a significant amount of polyubiquitinated proteins with the mitochondrial outer membrane (Fig. 2D) . However, a substantial portion of the ubiquitin conjugates that are resistant to the high pH buffer and, as a result, remain associated is reminiscent of some integral membrane proteins or of proteins with tight membrane interactions (Fig. 2D) . Taken together with the presence of several mitochondrial-associated E3 ligases [31] [32] [33] and deubiquitinating enzymes [34, 35] , this observation raises the possibility that some mitochondrial membrane proteins could undergo hyperubiquitination. The idea was substantiated by using an in vitro cell-free ubiquitination assay, demonstrating that mitochondrial proteins are ready for ubiquitination/polyubiquitination modification (Fig. 2E) . The mitochondrial proteins that are targets of hyperubiquitination are not currently well characterized. Some mitochondrial proteins previously shown to undergo ubiquitination modification are DJ-1 [15] , prohibitin [36] , aconitate hydratase, ATP synthase alpha chain, isocitrate dehydrogenase precursor, aspartate aminotransferase precursor, malate dehydrogenase precursor [37] , mitofusin [38] , and mitochondrial protein hFis1 and Drp1 [33] . The mitochondrial outer membrane protein, Fzo 1, which is subjected to proteasome dependent degradation, remains associated even after ubiquitination [39] . A previous study suggested neuroprotective roles for both Parkin, an E3 ligase associated with the mitochondrial outer membrane [31] , and the mitochondrial resident proteins, DJ1 and PINK1, in mitochondria-mediated apoptosis [31, 40, 41] , indicating that proteasome inhibitors may impair the functions of these proteins in the mitochondria. Additionally, Parkin-knockout mice revealed gross mitochondrial pathology [42] . A recent study demonstrated that polyubiquitination of misfolded DJ-1 by Parkin facilitates its targeting to aggresomes [15] .
Accumulation of mitochondrial ubiquitin conjugates likely represents a key early cellular response during neuronal stress since ubiquitin conjugates have also been reported to accumulate in the mitochondria of cortical and hippocampal neurons following cerebral ischaemia [43] . (Fig. 4B-D [25] . However, we found that mitochondrial superoxide production (Fig. 3C ) and glutathione levels (Fig. 3D 
